Scrip Dividend Declaration

Released : 18.04.2017 07:00

RNS Number : 3254C
Assura PLC
18 April 2017
 

18 April 2017

Assura plc

Scrip Dividend Declaration

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 19 April 2017 (the "Scrip Dividend Alternative"), elections were received in respect of 9 per cent. of the Company's ordinary shares in issue as at the record date of 17 March 2017.

Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 1,514,247 Shares (the "New Shares") will be issued by the Company to such shareholders.

Application has therefore been made for the admission of the New Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 19 April 2017.

Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 1,656,555,240 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 1,656,555,240.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

No Property Income Distribution ("PID") is included in this interim dividend. However, forms to register for gross PIDs (when these become payable) are available on the Company's website. Please click here for PID Forms.

 

-ENDS-

Enquiries

Assura plc

Tel: 01925 420660

Orla Ball


Finsbury

Tel: 0207 251 3801

Gordon Simpson


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2016, Assura's property portfolio was valued at £1,227 million.

 

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVGCGDSXBBBGRD